Long-term study of hepatitis B virus mutations in a patient resistant to multiple therapies
Author Information
Author(s): Cassino Lucila, Benetti Silvina, Fay Fabian, Tanno Hugo, Quarleri Jorge
Primary Institution: Centro Nacional de Referencia para el SIDA, Departamento de Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina
Hypothesis
How does hepatitis B virus genomic evolution occur during antiviral therapy in a patient with previous resistance to lamivudine?
Conclusion
The study found that the patient continued to have high viral loads and resistance mutations despite multiple antiviral therapies over 14 years.
Supporting Evidence
- The patient had a history of lamivudine resistance.
- Multiple antiviral therapies were attempted over 14 years.
- High viral loads persisted despite treatment changes.
Takeaway
This study followed a woman with hepatitis B for 14 years to see how the virus changed when she was treated with different medicines. Even though she tried many treatments, the virus kept coming back.
Methodology
The study involved amplifying and sequencing HBV genes, measuring viral load, and monitoring serological profiles over 14 years.
Limitations
The study is based on a single case, which may limit the generalizability of the findings.
Participant Demographics
A 47-year-old woman diagnosed with chronic active HBeAg-positive hepatitis B.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website